Status:
COMPLETED
Testing of Identification Markers for Stroke
Lead Sponsor:
POCKiT diagnostics Ltd
Collaborating Sponsors:
University of Alabama at Birmingham
University of Mississippi Medical Center
Conditions:
Stroke, Ischemic
Infarction, Middle Cerebral Artery
Eligibility:
All Genders
18+ years
Brief Summary
Stroke is the third leading cause of death and the first cause of physical disability and dementia worldwide. Ischemic stroke caused by large vessel occlusion (LVO) is responsible for the vast majorit...
Detailed Description
Stroke affects 16M people in the world every year and 100K in the UK only. More than 30% of these patients die and 90% of survivors develop permanent disabilities as a consequence of stroke. There are...
Eligibility Criteria
Inclusion
- Referred to the ambulance or emergency department for suspected stroke.
- Time from stroke onset \< 18 hours
Exclusion
- Received thrombolytic therapy (e.g. tPA, Alteplase) before collection of blood;
- (Anticipated) inability to provide a blood sample;
- Time from stroke onset \> 18 hours.
- At time of consent participating in a Clinical Trial Investigational Medicinal Product (CTIMP)
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
383 Patients enrolled
Trial Details
Trial ID
NCT04292600
Start Date
May 1 2021
End Date
January 31 2023
Last Update
April 3 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama in Birmingham Comprehensive Stroke Center
Birmingham, Alabama, United States, 35294
2
BAC Telemed - Brandon Regional Hospital
Brandon, Florida, United States, 33511
3
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216